181 related articles for article (PubMed ID: 12470131)
1. Dopamine antagonists and the development of breast cancer.
Wang PS; Walker AM; Tsuang MT; Orav EJ; Glynn RJ; Levin R; Avorn J
Arch Gen Psychiatry; 2002 Dec; 59(12):1147-54. PubMed ID: 12470131
[TBL] [Abstract][Full Text] [Related]
2. Are dopamine antagonists a risk factor for breast cancer? An answer from Parkinson's disease.
Lalonde FM; Myslobodsky M
Breast; 2003 Aug; 12(4):280-2. PubMed ID: 14659314
[TBL] [Abstract][Full Text] [Related]
3. Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs: An Observational Study of US Women (Ages 18-64 Years).
Rahman T; Sahrmann JM; Olsen MA; Nickel KB; Miller JP; Ma C; Grucza RA
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):7-16. PubMed ID: 34864772
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant use and the risk of breast cancer: a non-association.
Wang PS; Walker AM; Tsuang MT; Orav EJ; Levin R; Avorn J
J Clin Epidemiol; 2001 Jul; 54(7):728-34. PubMed ID: 11438414
[TBL] [Abstract][Full Text] [Related]
5. Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control study.
Pottegård A; Lash TL; Cronin-Fenton D; Ahern TP; Damkier P
Br J Clin Pharmacol; 2018 Sep; 84(9):2152-2161. PubMed ID: 29858518
[TBL] [Abstract][Full Text] [Related]
6. Post-diagnostic antipsychotic use and cancer mortality: a population based cohort study.
Hicks BM; Busby J; Mills K; O'Neil FA; McIntosh SA; Zhang SD; Liberante FG; Cardwell CR
BMC Cancer; 2020 Aug; 20(1):804. PubMed ID: 32831062
[TBL] [Abstract][Full Text] [Related]
7. Risk of breast cancer in risperidone users: A nationwide cohort study.
Reutfors J; Wingård L; Brandt L; Wang Y; Qiu H; Kieler H; Bahmanyar S
Schizophr Res; 2017 Apr; 182():98-103. PubMed ID: 27823949
[TBL] [Abstract][Full Text] [Related]
8. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
[TBL] [Abstract][Full Text] [Related]
9. [Ziprasidone. A new second-generation antipsychotic agent].
Lublin HK
Ugeskr Laeger; 2004 Mar; 166(14):1334-9. PubMed ID: 15101124
[No Abstract] [Full Text] [Related]
10. Human relevance of rodent prolactin-induced non-genotoxic mammary carcinogenesis: prolactin involvement in human breast cancer and significance for toxicology risk assessments.
Harvey PW
J Appl Toxicol; 2005; 25(3):179-83. PubMed ID: 15856525
[TBL] [Abstract][Full Text] [Related]
11. Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
Wang PS; Schneeweiss S; Avorn J; Fischer MA; Mogun H; Solomon DH; Brookhart MA
N Engl J Med; 2005 Dec; 353(22):2335-41. PubMed ID: 16319382
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotics and the risk of sudden cardiac death.
Ray WA; Meredith S; Thapa PB; Meador KG; Hall K; Murray KT
Arch Gen Psychiatry; 2001 Dec; 58(12):1161-7. PubMed ID: 11735845
[TBL] [Abstract][Full Text] [Related]
13. Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.
De Hert M; Peuskens J; Sabbe T; Mitchell AJ; Stubbs B; Neven P; Wildiers H; Detraux J
Acta Psychiatr Scand; 2016 Jan; 133(1):5-22. PubMed ID: 26114737
[TBL] [Abstract][Full Text] [Related]
14. [Prolactin, antipsychotics and breast cancer: is there a connection?].
Sabbe T; Detraux J; De Hert M
Tijdschr Psychiatr; 2016; 58(9):641-9. PubMed ID: 27639886
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer in hospitalized psychiatric patients.
Goode DJ; Corbett WT; Schey HM; Suh SH; Woodie B; Morris DL; Morrisey L
Am J Psychiatry; 1981 Jun; 138(6):804-6. PubMed ID: 6113769
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue.
Schyve PM; Smithline F; Meltzer HY
Arch Gen Psychiatry; 1978 Nov; 35(11):1291-1301. PubMed ID: 30426
[TBL] [Abstract][Full Text] [Related]
17. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.
Mehta S; Johnson ML; Chen H; Aparasu RR
J Clin Psychiatry; 2010 Jun; 71(6):689-98. PubMed ID: 20573328
[TBL] [Abstract][Full Text] [Related]
18. [Breast cancer in the family: a possible contra-indication to the use of dopamine antagonists. A case study].
Nijpels MA; Harnisch E; Gijsbers van Wijk CM
Tijdschr Psychiatr; 2006; 48(6):481-5. PubMed ID: 16956008
[TBL] [Abstract][Full Text] [Related]
19. The use of atypical antipsychotics and the risk of breast cancer.
Azoulay L; Yin H; Renoux C; Suissa S
Breast Cancer Res Treat; 2011 Sep; 129(2):541-8. PubMed ID: 21479550
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic treatment, prolactin, and breast tumorigenesis.
De Hert M; Vancampfort D; Stubbs B; Sabbe T; Wildiers H; Detraux J
Psychiatr Danub; 2016 Sep; 28(3):243-254. PubMed ID: 27658833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
